Existing extended-release options, like weekly formulations of semaglutide and dulaglutide, have reduced injection frequency, and future innovations may include monthly formulations or implantable devices that deliver continuous therapy
Without health insurance, the drugs can cost thousands of dollars per month
Consoli, A., & Formoso, G
If your provider recommends a compounded formulation, understanding proper semaglutide reconstitution or tirzepatide reconstitution becomes essential
Prospects of GLP-1 Therapies for Addiction and Mental Health ComorbiditiesQuo Vadis
Patients with higher starting weights often respond well to tirzepatide dual mechanism